Click a link below to view the mailing archive as if it had been sent to you.
| 2022-07-29 12:15 | | Sarepta shares buoyed by pledge to seek an early swift review for Duchenne gene therapy and more... |
| 2022-07-29 00:15 | | Drugmakers leap back into fading heart drug market and more... |
| 2022-07-28 12:15 | | The NASH curse strikes again. Pfizer dumps early-stage asset for liver condition and more... |
| 2022-07-28 00:15 | | Senate Finance chair calls on Merck and Abbott to comply with his investigation into their offshore tax schemes and more... |
| 2022-07-27 12:15 | | Biogen, watch out: Novartis' Tysabri biosim application could portend multiple sclerosis showdown in Europe and US and more... |
| 2022-07-27 00:15 | | Novartis fails to win appeal in whistleblower case involving cancer drug study and more... |
| 2022-07-26 12:15 | | Seagen, Astellas claim positive results in study key to cancer drug's success and more... |
| 2022-07-26 00:15 | | Philips predicts sleep machine sales to recover by 2025 as ventilator recall rages on and more... |
| 2022-07-25 12:15 | | AstraZeneca wins two recommendations, one priority review and more... |
| 2022-07-25 00:15 | | iRhythm snags FDA approval for AFib characterization algorithm used in Verily’s wearable and more... |
| 2022-07-22 12:15 | | Amazon primed to disrupt healthcare with purchase of One Medical and more... |
| 2022-07-22 00:15 | | Assembly Bio scraps hepatitis B drug, cuts staff after clinical setback and more... |
| 2022-07-21 12:15 | | Roche CEO Severin Schwan to step down after 14 years and more... |
| 2022-07-21 00:15 | | Bristol Myers launches program to make clinical trials more accessible for people with disabilities and more... |
| 2022-07-20 12:15 | | Jazz’s toehold on sleep market slips with tentative Avadel FDA approval and more... |
| 2022-07-20 00:15 | | Pharma's new 'Berlin Declaration' seeks to reserve vaccines, therapeutics in production for low-income countries and more... |
| 2022-07-19 12:15 | | Ultragenyx buys gene therapy partner after new study results and more... |
| 2022-07-19 00:15 | | Eisai closing oncology R&D wing H3 Biomedicine for good and more... |
| 2022-07-18 12:15 | | Biotech employees cash in health care’s largest salaries, while people working at providers sit near the bottom and more... |
| 2022-07-18 00:15 | | GSK has a chance to prove itself after next week's Haleon split. Will M&A follow? and more... |
| 2022-07-16 00:15 | | Ex-Novartis sales rep claims discrimination, retaliation led to her firing after she reported misconduct and more... |
| 2022-07-15 12:15 | | AbbVie pens Imbruvica supply pact to support pivotal Oncternal trial and more... |
| 2022-07-15 00:15 | | Pharma hiring continues to grow in the US and talent competition remains tight — report and more... |
| 2022-07-14 12:15 | | Over-the-counter birth control pills are available worldwide. The U.S. may be next and more... |
| 2022-07-14 00:15 | | FDA authorizes Novavax Covid vaccine, in hopes the traditional shot will convince holdouts and more... |
| 2022-07-13 12:15 | | Will Biotech Unicorns Soon Be on The Endangered Species List? and more... |
| 2022-07-13 00:15 | | FDA rule would facilitate prescription-to-OTC switches but nix a third class of drugs and more... |
| 2022-07-12 12:15 | | Sanofi offloads 17 brands to Neuraxpharm and more... |
| 2022-07-12 00:15 | | Ionis hands off an antisense drug for kidney disease, giving all rights to Roche and more... |
| 2022-07-11 12:15 | | Moderna's Omicron bivalent booster candidate demonstrates significantly higher neutralizing antibody response against Omicron BA.4/5 than current booster and more... |
| 2022-07-11 00:15 | | Insilico's AI Identifies Potential New Therapeutic Targets for ALS and more... |
| 2022-07-08 12:15 | | After a lengthy drought, could biotech M&A be on the upswing? and more... |
| 2022-07-08 00:15 | | 6 Medtech Acquisitions That Went Horribly Wrong and more... |
| 2022-07-07 12:15 | | Report: Merck in Advanced Talks to Acquire Seagen for $40B and more... |
| 2022-07-07 00:15 | | Pharmacists Can Prescribe Pfizer’s Covid Antiviral Paxlovid, FDA Says and more... |
| 2022-07-06 12:15 | | FDA Has Ways to Go to Keep Pace with 2020/21 Approvals and more... |
| 2022-07-06 00:15 | | Biogen-Eisai go for another biomarker approval in Alzheimer's with lecanemab—and snag priority review and more... |
| 2022-07-05 12:15 | | AstraZeneca agrees $1.3bn deal to buy oncology player TeneoTwo and more... |
| 2022-07-05 00:15 | | Regeneron completes acquisition of Sanofi’s stake in Libtayo and more... |
| 2022-07-01 12:15 | | Oxford Biomedica signs up for 3 more years of making AstraZeneca COVID shots—on an 'as needed basis' and more... |
| 2022-07-01 00:15 | | Blueprint secures access to more than $1B in funding through two new deals and more... |
